VOLITIONRX LTD — Director's Dealing 2015

Jul 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-07-23

Reporting Person: Reynolds Cameron John (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-23	Stock Option	$4	A	55000	Acquired	2020-01-23	Common Stock (55000)	Direct

Footnotes

F1: A total of 55,000 Options were granted on July 23, 2015 under the Company's 2011 Equity Incentive Plan. The Options vest in full six months from the date of grant.